26 results
8-K
EX-2.1
RVLPQ
RVL Pharmaceuticals plc
27 Nov 23
Bankruptcy or Receivership
4:06pm
in the singular or the plural, shall include both the singular and the plural, and pronouns stated in the masculine, feminine, or neuter gender shall include … the masculine, feminine, and the neuter gender; (b) unless otherwise specified, any reference herein to a contract, lease, instrument, release, indenture
8-K
EX-99.1
RVLPQ
RVL Pharmaceuticals plc
13 Oct 23
Termination of a Material Definitive Agreement
4:15pm
, and pronouns stated in the masculine, feminine, or neuter gender shall include the masculine, feminine, and the neuter gender; (b) unless otherwise
8-K
EX-3.1
9qqndantia 1i
18 Jan 22
Amendments to Articles of Incorporation or Bylaws
8:16am
8-K
EX-2.1
q2mo7 08f
30 Jun 21
Osmotica Pharmaceuticals plc Announces Conclusion of Strategic Process with Agreement for the Sale of Legacy Business to Alora Pharmaceuticals, LLC
6:04am
8-K
EX-99.1
ptck52l
31 Jul 20
Is (I) Not Material and (Ii) Would Likely Cause Competitive Harm to the Company If
4:33pm
S-3
EX-4.7
lvtjj1 jzybr5j
31 Jan 20
Shelf registration
4:07pm
DEF 14A
knd8izgz3tlb 2hv
26 Apr 19
Definitive proxy
4:09pm
10-K
EX-4.1
nq88t 2caq
28 Mar 19
Annual report
12:00am
10-K
EX-3.1
ntraouscd4y4m
28 Mar 19
Annual report
12:00am
10-Q
llry5dk4ahp7lz58
8 Nov 18
Quarterly report
4:03pm
S-8
EX-4.1
f5yc 3piqj7b8huz1a
29 Oct 18
Registration of securities for employees
5:16pm
S-1/A
EX-3.1
0zjdjt
1 Oct 18
IPO registration (amended)
12:00am
S-1/A
EX-4.1
swlqhkbr23ju62c3t5l
1 Oct 18
IPO registration (amended)
12:00am